Parietal lobe ependymal tumor

Summary

Parietal lobe ependymal tumor (MONDO:0000520) is a cancer. A subtype of parietal lobe cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	parietal lobe ependymal tumor
Mondo ID	MONDO:0000520
DOID	DOID:0050903
NCIT	C131575
UMLS	C4330935
MedGen	1392382
GARD	0022789
Anatomy (UBERON)	UBERON:0001872
Is cancer (heuristic)	yes

Also known as: ependymal tumor of parietal lobe · ependymal tumour of parietal lobe · parietal lobe ependymal tumor

Disease family

Classification path: cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › brain cancer › supratentorial cancer › cerebral hemisphere cancer › parietal lobe cancer › parietal lobe ependymal tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.